Results 121 to 130 of about 588,781 (167)

Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance data. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2021
Otani Y, Kasai H, Tanigawara Y.
europepmc   +1 more source

Postmarketing surveillance of brentuximab vedotin for previously untreated Hodgkin lymphoma in Japanese patients. [PDF]

J Clin Exp Hematop
Okazuka K, Shimizu T, Tawara R, Matsuo M, Ichihara K, Izutsu K.   +5 more
europepmc   +1 more source

Peri-procedural and 6-month outcomes of rotational atherectomy for highly calcified femoropopliteal lesions from Japanese postmarketing surveillance. [PDF]

Heart Vessels
Soga Y, Urasawa K, Tsujimura T, Yamamoto Y, Fujihara M, Nakama T, Haraguchi T, Tobita K.   +7 more
europepmc   +1 more source

Interim results from a postmarketing surveillance study of patients with FLT3-mutated relapsed/refractory AML treated with the FLT3 inhibitor gilteritinib in Japan. [PDF]

Jpn J Clin Oncol, 2022
Sugamori H, Lee T, Mitomi T, Yamagishi C.   +3 more
europepmc   +1 more source

Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data. [PDF]

Front Pharmacol, 2022
Zhao Q, Ma P, Fu P, Wang J, Wang K, Chen L, Yang Y.   +6 more
europepmc   +1 more source

Postmarketing Surveillance

, 1994
Vandenburg, Malcolm, Winman, William H.
core  

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real-World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data. [PDF]

Pharmacotherapy
Rahurkar S, Ouyang J, Jonnalagadda P, Liu X, Zhang S, Chiang CW, Wang L, Shendre A, Li L.   +8 more
europepmc   +1 more source

Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. [PDF]

Neurooncol Adv, 2022
Iuchi T, Inoue A, Hirose Y, Morioka M, Horiguchi K, Natsume A, Arakawa Y, Iwasaki K, Fujiki M, Kumabe T, Sakata Y.   +10 more
europepmc   +1 more source

Safety and effectiveness of stiripentol in patients with Dravet syndrome: A prospective, 3-year, postmarketing surveillance study. [PDF]

Dev Med Child Neurol
Kitamura Y, Ohyabu H, Miura T, Takei-Masuda N, Matsui D, Inoue Y, Ohtsuka Y.   +6 more
europepmc   +1 more source

Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data. [PDF]

Front Pharmacol, 2022
Zhao Q, Ma P, Fu P, Wang J, Wang K, Chen L, Yang Y.   +6 more
europepmc   +1 more source